Related Experiment Video
Updated: Feb 10, 2026

Using Reference Reagents to Confirm Robustness of Cytokine Release Assays for the Prediction of Monoclonal Antibody Safety
Published on: September 15, 2023
Informative graphing of continuous safety variables relative to normal reference limits
Christopher D Breder1,2,3
1Division of Neurology Products, Food and Drug Administration, Silver Spring, MD, USA. cbreder1@jhu.edu.
Background:
Interpreting graphs of continuous safety variables can be complicated because differences in age, gender, and testing site methodologies data may give rise to multiple reference limits. Furthermore, data below the lower limit of normal are compressed relative to those points above the upper limit of normal. The objective of this study is to develop a graphing technique that addresses these issues and is visually intuitive.
Methods:
A mock dataset with multiple reference ranges is initially used to develop the graphing technique. Formulas are developed for conditions where data are above the upper limit of normal, normal, below the lower limit of normal, and below the lower limit of normal when the data value equals zero. After the formulae are developed, an anonymized dataset from an actual set of trials for an approved drug is evaluated comparing the technique developed in this study to standard graphical methods.
Results:
Formulas are derived for the novel graphing method based on multiples of the normal limits. The formula for values scaled between the upper and lower limits of normal is a novel application of a readily available scaling formula. The formula for the lower limit of normal is novel and addresses the issue of this value potentially being indeterminate when the result to be scaled as a multiple is zero.
Conclusions:
The formulae and graphing method described in this study provides a visually intuitive method to graph continuous safety data including laboratory values, vital sign data.
Related Concept Videos
Graphs of Equations in Two Variables
Variation: Normal Distribution, Range, and Standard Deviation
Limiting Reactant
Survey Safety
Ogive Graph
Graphing Antiderivatives

